(S)-N-{3-[1-Cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: A Potent, Nonsteroidal, Functional Antagonist of the Mineralocorticoid Receptor
Authors:
- 27 November 2007
- journal article
- letter
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 50 (26) , 6443-6445
Abstract
A novel, potent series of indole analogs were recently developed as MR antagonists, culminating in 14. This compound represents the first MR antagonist in this class of molecules, exhibiting picomolar binding affinity and in vivo blood pressure lowering at pharmaceutically relevant doses.Keywords
This publication has 8 references indexed in Scilit:
- Enantiomeric separation of mineralocorticoid receptor (hMR) antagonists using the Chiralcel® OJ‐H HPLC column with novel polar cosolvent eluent systemsChirality, 2006
- 3,3-Bisaryloxindoles as mineralocorticoid receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2005
- Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart FailureCirculation, 1999
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Molecular Biology of Mineralocorticoid MetabolismAnnual Review of Nutrition, 1996
- Prostanoids and aldosterone-induced mild experimental hypertension in rats.Hypertension, 1990
- Antialdosterones: Incidence and prevention of sexual side effectsJournal of Steroid Biochemistry, 1989
- Effect of lipophilic substituents on some biological properties of indolesJournal of Medicinal Chemistry, 1974